Health
PSMA-Directed Therapies and Diagnostics Expand Their Scope in Prostate Cancer – Targeted Oncology
With the emergence of therapies that target PSMA, a cell surface transmembrane protein that is overexpressed in most prostate cancer cells, particularly in castration-resistant…
The December 2020 approval of the first agent for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA)positive lesions in patients with prostate cancer, Gallium 68 PSMA-11 (Ga 68 PSMA-11), heralded an exciting new chapter in the diagnosis and treatment of metastatic castration-resistant prostate cancer (mCRPC). With the emergence of therapies that target PSMA, a cell surface transmembrane protein that is overexpressed in most prostate cancer cells, particularly…
-
Noosa News23 hours agoAustralian growers expect to benefit from US tariffs as Trump’s trade war angers markets
-
Noosa News21 hours agoDisaster relief packages announced for flood-stricken western Queensland
-
Noosa News23 hours agoHow to get the most from potted citrus and when they’ll fruit
-
General23 hours agoPeter Dutton partially walks back public service work-from-home vow